WHO ICTRP trial
The effect of giloy satva and ghana in diabetes
CTRI/2012/01/002368 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2012/01/002368 |
|---|---|
| Public title | The effect of giloy satva and ghana in diabetes |
| Scientific title | THE EFFECT OF TWO DIFFERENT DOSAGE FORMS OF GUDUCHI i.e. SATVA AND GHANA W.S.R. ANTI HYPERGLYCEMIC EFFECT ON MADHUMEHA (DIABETES MELLITUS) |
| Primary sponsor | IPGT and RA Gujarat Ayurved University |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- MADHUMEHA (DIABETES MELLITUS) |
| Interventions | Intervention1: Guduchi satva: 500 mg BD with water for 28 days Control Intervention1: Guduchi ghana: 500 mg BD with water for 28 days |
| Registration date | Jan 24, 2012 |
| Target size | 90 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: